Literature DB >> 19234476

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Hellmut G Augustin1, Gou Young Koh, Gavin Thurston, Kari Alitalo.   

Abstract

Angiogenesis, the growth of blood vessels, is a fundamental biological process that controls embryonic development and is also involved in numerous life-threatening human diseases. Much work in the field of angiogenesis research has centred on the vascular endothelial growth factor (VEGF)-VEGF receptor system. The Tie receptors and their angiopoietin (Ang) ligands have been identified as the second vascular tissue-specific receptor Tyr kinase system. Ang-Tie signalling is essential during embryonic vessel assembly and maturation, and functions as a key regulator of adult vascular homeostasis. The structural characteristics and the spatio-temporal regulation of the expression of receptors and ligands provide unique insights into the functions of this vascular signalling system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234476     DOI: 10.1038/nrm2639

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  152 in total

1.  The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism.

Authors:  Marion Scharpfenecker; Ulrike Fiedler; Yvonne Reiss; Hellmut G Augustin
Journal:  J Cell Sci       Date:  2005-02-01       Impact factor: 5.285

2.  Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor.

Authors:  Brian L Hodous; Stephanie D Geuns-Meyer; Paul E Hughes; Brian K Albrecht; Steve Bellon; James Bready; Sean Caenepeel; Victor J Cee; Stuart C Chaffee; Angela Coxon; Maurice Emery; Jenne Fretland; Paul Gallant; Yan Gu; Doug Hoffman; Rebecca E Johnson; Richard Kendall; Joseph L Kim; Alexander M Long; Michael Morrison; Philip R Olivieri; Vinod F Patel; Anthony Polverino; Paul Rose; Paul Tempest; Ling Wang; Douglas A Whittington; Huilin Zhao
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

3.  Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis.

Authors:  Antti I Nykänen; Rainer Krebs; Anne Saaristo; Päivi Turunen; Kari Alitalo; Seppo Ylä-Herttuala; Petri K Koskinen; Karl B Lemström
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells.

Authors:  Injune Kim; Jong-Lark Oh; Young Shin Ryu; June-No So; William C Sessa; Kenneth Walsh; Gou Young Koh
Journal:  FASEB J       Date:  2001-11-29       Impact factor: 5.191

Review 5.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

Authors:  J Holash; S J Wiegand; G D Yancopoulos
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

6.  Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells.

Authors:  Christopher Daly; Elizabeth Pasnikowski; Elena Burova; Vivian Wong; Thomas H Aldrich; Jennifer Griffiths; Ella Ioffe; Thomas J Daly; James P Fandl; Nick Papadopoulos; Donald M McDonald; Gavin Thurston; George D Yancopoulos; John S Rudge
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

7.  Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity.

Authors:  W N Procopio; P I Pelavin; W M Lee; N M Yeilding
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

8.  COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity.

Authors:  Chung-Hyun Cho; Richard A Kammerer; Hyuek Jong Lee; Michel O Steinmetz; Young Shin Ryu; Sung Ho Lee; Kunio Yasunaga; Kyung-Tae Kim; Injune Kim; Han-Ho Choi; Won Kim; Sung Hyun Kim; Sung Kwang Park; Gyun Min Lee; Gou Young Koh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-01       Impact factor: 11.205

9.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development.

Authors:  M C Puri; J Partanen; J Rossant; A Bernstein
Journal:  Development       Date:  1999-10       Impact factor: 6.868

View more
  507 in total

1.  The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier.

Authors:  Yueru Li; Zhonghao Yan; Komal Chaudhry; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2020-06-23       Impact factor: 4.307

Review 2.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

3.  Tie1 deficiency induces endothelial-mesenchymal transition.

Authors:  Julie Garcia; Maria José Sandi; Pierre Cordelier; Bernard Binétruy; Jacques Pouysségur; Juan Lucio Iovanna; Roselyne Tournaire
Journal:  EMBO Rep       Date:  2012-05-01       Impact factor: 8.807

Review 4.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 5.  Formation of cardiovascular tubes in invertebrates and vertebrates.

Authors:  Boris Strilić; Tomás Kucera; Eckhard Lammert
Journal:  Cell Mol Life Sci       Date:  2010-05-20       Impact factor: 9.261

Review 6.  Microvascular rarefaction: the decline and fall of blood vessels.

Authors:  Michael S Goligorsky
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

7.  Excess Maternal Thyroxine Alters the Proliferative Activity and Angiogenic Profile of Growth Cartilage of Rats at Birth and Weaning.

Authors:  Lorena Gabriela Rocha Ribeiro; Juneo Freitas Silva; Natália de Melo Ocarino; Cíntia Almeida de Souza; Eliane Gonçalves de Melo; Rogéria Serakides
Journal:  Cartilage       Date:  2016-12-28       Impact factor: 4.634

Review 8.  Cellular and molecular regulation of vascular permeability.

Authors:  Lauren M Goddard; M Luisa Iruela-Arispe
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

9.  Cardiac fibroblasts support endothelial cell proliferation and sprout formation but not the development of multicellular sprouts in a fibrin gel co-culture model.

Authors:  Rachel L Twardowski; Lauren D Black
Journal:  Ann Biomed Eng       Date:  2014-01-17       Impact factor: 3.934

10.  Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy.

Authors:  Gabriela D'Amico; Emilia A Korhonen; Andrey Anisimov; Georgia Zarkada; Tanja Holopainen; René Hägerling; Friedemann Kiefer; Lauri Eklund; Raija Sormunen; Harri Elamaa; Rolf A Brekken; Ralf H Adams; Gou Young Koh; Pipsa Saharinen; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.